EXOC6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.288400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.310800E-01
Normal-vs-Stage2
4.516400E-01
Normal-vs-Stage3
8.360300E-02
Normal-vs-Stage4
7.249600E-01
Stage1-vs-Stage2
3.973800E-01
Stage1-vs-Stage3
3.574400E-01
Stage1-vs-Stage4
8.708000E-01
Stage2-vs-Stage3
4.367800E-01
Stage2-vs-Stage4
6.623800E-01
Stage3-vs-Stage4
3.147600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.053200E-01
Normal-vs-AfricanAmerican
9.315800E-01
Normal-vs-Asian
6.207000E-01
Caucasian-vs-AfricanAmerican
2.790600E-01
Caucasian-vs-Asian
7.500800E-01
AfricanAmerican-vs-Asian
5.223000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.284400E-01
Normal-vs-Female
4.003400E-01
Male-vs-Female
3.930800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.183600E-01
Normal-vs-Age(41-60Yrs)
7.192800E-01
Normal-vs-Age(61-80Yrs)
3.786400E-01
Normal-vs-Age(81-100Yrs)
7.365000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.073200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.724600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.338600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.637400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.766400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.431000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.272600E-01
Normal-vs-Daily Drinker
4.039000E-01
Normal-vs-Weekly Drinker
4.148400E-01
Normal-vs-Occasional Drinker
8.518200E-01
Normal-vs-Social Drinker
3.222400E-01
Non Drinker-vs-Daily Drinker
5.752200E-01
Non Drinker-vs-Weekly Drinker
5.883800E-01
Non Drinker-vs-Occasional Drinker
6.530400E-01
Non Drinker-vs-Social Drinker
3.731800E-01
Daily Drinker-vs-Weekly Drinker
9.582400E-01
Daily Drinker-vs-Occasional Drinker
4.087400E-01
Daily Drinker-vs-Social Drinker
7.197800E-01
Weekly Drinker-vs-Occasional Drinker
4.635200E-01
Weekly Drinker-vs-Social Drinker
7.884800E-01
Occasional Drinker-vs-Social Drinker
3.293600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.378400E-02
Normal-vs-Grade 2
2.355700E-02
Normal-vs-Grade 3
5.353600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.034780E-01
Grade 1-vs-Grade 3
2.106200E-01
Grade 1-vs-Grade 4
6.378400E-02
Grade 2-vs-Grade 3
6.103800E-01
Grade 2-vs-Grade 4
2.355700E-02
Grade 3-vs-Grade 4
5.353600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.291400E-01
Normal-vs-NonDiabetic
3.976800E-01
Diabetic-vs-NonDiabetic
8.402600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.600000E-02
Normal-vs-NoPancreatitis
4.920400E-01
Pancreatitis-vs-NoPancreatitis
1.734650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.531600E-01
Normal-vs-N1
4.375600E-01
N0-vs-N1
3.058400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.361000E-01
Normal-vs-TP53-NonMutant
9.454200E-01
TP53-Mutant-vs-TP53-NonMutant
3.520100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
